Premarket Mover: PainReform Ltd (PRFX) Up 2.13%

PainReform Ltd (PRFX) is higher by Thursday morning, with the stock increasing 2.13% in pre-market trading to 6.71. PRFX's short-term technical score of 35 indicates that the stock has traded less bullishly over the last month than 65% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 138 out of 146 industries, PRFX ranks higher than 60% of stocks. PainReform Ltd has risen 2.02% over the past month, closing at $5.55 on July 6. During this period of time, the stock fell as low as $4.05 and as high as $26.41. PRFX has an average analyst recommendation of Strong Buy. The company has an average price target of $20.00.

PRFX has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on PRFX!

See Full PRFX Report

PainReform Ltd has a Long-Term Technical rank of 76. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 24% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 137 by this metric, PRFX ranks better than 137% of stocks.

Important Dates for Investors in PRFX:

-PainReform Ltd is set to release earnings on 8/21/2023. Over the last 12 months, the company has reported EPS of $-0.82. -We do not have a set dividend date for PainReform Ltd at this time. Click Here To Get The Full Report on PainReform Ltd (PRFX)